Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Comprehensive Income [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 82 $ 14,486,492 $ (13,878,553) $ (42,832) $ 565,189
Beginning balance, shares at Dec. 31, 2020 817,450        
Issuance of common related to offering $ 288 12,661,696 12,661,984
Issuance of common related to offering, shares 2,880,000        
Comprehensive income (loss) 42,850 42,850
Net loss (4,567,085) (4,567,085)
Issuance common stock from convertible debt $ 135 1,644,132 1,644,267
Issuance common stock from convertible debt, shares 1,345,468        
Issuance of common for over-allotment $ 43 1,983,226 1,983,269
Issuance of commom fot over - allotment, shares 432,000        
Issuance of warrants for over-allotment 4,320 4,320
Issuance of common stock from exercise of warrant $ 92 4,629,448 4,629,540
Issuance of common stock from exercise of warrant, shares 925,908        
Issuance of common stock related to exercise of options $ 2 4,998 5,000
Issuance of common stock related to exercise of options, shares 17,437        
Stock based compensation in connection with options granted 1,053,064 1,053,064
Stock based compensation in relation to restricted stock award $ 5 268,495 268,500
Stock based compensation in connection with restricted stock awards, shares 50,000        
Issuance of common stock for services 14,200 14,200
Issuance of common for services, shares 1,000        
Beneficial conversion feature of convertible debt 340,420 340,420
Ending balance, value at Sep. 30, 2021 $ 647 37,090,491 (18,445,638) 18 18,645,518
Ending balance, shares at Sep. 30, 2021 6,469,263        
Beginning balance, value at Dec. 31, 2020 $ 82 14,486,492 (13,878,553) (42,832) $ 565,189
Beginning balance, shares at Dec. 31, 2020 817,450        
Issuance of common stock related to exercise of options, shares         19,200
Ending balance, value at Dec. 31, 2021 $ 705 39,513,093 (21,986,215) 3,236 $ 17,530,819
Ending balance, shares at Dec. 31, 2021 7,053,146        
Beginning balance, value at Jun. 30, 2021 $ 548 31,139,486 (16,140,089) (55,566) 14,944,379
Beginning balance, shares at Jun. 30, 2021 5,476,918        
Comprehensive income (loss) 55,584 55,584
Net loss (2,305,549) (2,305,549)
Issuance of common stock related to exercise of options $ 2 4,998 5,000
Issuance of common stock related to exercise of options, shares 17,437        
Stock based compensation for options granted 1,053,064 1,053,064
Stock based compensation for restricted stock awards 5 268,495 268,500
Stock based compensation for restricted stock awards, shares 50,000        
Issuance of common stock from exercise warrant $ 92 4,624,448 4,624,540
Issuance of common stock from exercise warrant, shares 924,908        
Ending balance, value at Sep. 30, 2021 $ 647 37,090,491 (18,445,638) 18 18,645,518
Ending balance, shares at Sep. 30, 2021 6,469,263        
Beginning balance, value at Dec. 31, 2021 $ 705 39,513,093 (21,986,215) 3,236 17,530,819
Beginning balance, shares at Dec. 31, 2021 7,053,146        
Issuance of common related to offering $ 223 7,004,815 7,005,038
Issuance of common related to offering, shares 2,229,950        
Issuance of common related to restricted stock award $ 37 1,343,529 1,343,566
Issuance of common related to restricted stock award, shares 366,000        
Stock based compensation in relation to options granted 620,199 620,199
Comprehensive income (loss) (87,753) (87,753)
Net loss (8,219,220) $ (8,219,220)
Issuance of common stock related to exercise of options, shares        
Ending balance, value at Sep. 30, 2022 $ 965 48,481,636 (30,205,435) (84,517) $ 18,192,649
Ending balance, shares at Sep. 30, 2022 9,649,096        
Beginning balance, value at Jun. 30, 2022 $ 929 47,206,953 (24,492,159) (16,882) 22,698,841
Beginning balance, shares at Jun. 30, 2022 9,293,096        
Comprehensive income (loss) (67,635) (67,635)
Net loss (5,713,276) (5,713,276)
Stock based compensation in relation to restricted stock award $ 36 654,484 654,520
Stock based compensation in connection with restricted stock awards, shares 356,000        
Stock based compensation for options granted 620,199 620,199
Ending balance, value at Sep. 30, 2022 $ 965 $ 48,481,636 $ (30,205,435) $ (84,517) $ 18,192,649
Ending balance, shares at Sep. 30, 2022 9,649,096